Integrin aIIbb3 is indispensable for normal hemostasis, but its role for thrombopoiesisis still controversial. Recently, αIIb and β3 mutations have been identified in patients with congenital macrothrombocytopenia. We analyzed three unrelated Japanese families with congenital macrothrombocytopenia. Expression and activation state of αIIbβ3 in platelets was examined by flow cytometry and immunoblotting. Sequence of whole coding region and exon–intron boundariesof ITGA2B and ITGB3 genes was performed. The effects of mutations onaIIbb3 activation state and phosphorylation of FAK were analyzed in transfected cells. We newly identified three mutations: two mutations in highlyconserved Gly-Phe-Phe-Lys-Arg sequence in juxtamembrane region of αIIb,p.Gly991Cys and p.Phe993del, and one donor site mutation of intron 13 ofITGB3 leading to 40 amino acids deletion, p.(Asp621_Glu660del), in the membraneproximal β-tail domain of β3. One patient, who showed Glanzmann thrombasthenia-like marked reduction in surface αIIbβ3 expression (3–11% of normal control), was a compound heterozygote with ITGA2B p.Gly991Cys and a novel nonsense mutation, ITGA2B p.Arg422*. All three mutations, ITGA2Bp.Gly991Cys, ITGA2B p.Phe993del, and ITGB3 p.(Asp621_Glu660del), led tohighly activated conformation of αIIbβ3 and spontaneous tyrosine phosphorylationof FAK in transfected cells. These results suggest that gain-of-functionmutations around membrane region of aIIbb3 lead to abnormal platelet number and morphology with impaired surface aIIbb3 expression.
- Congenital macrothrombocytopeniagain-of-function mutations
- Glanzmann thrombasthenia
- Integrin αIIbβ3
ASJC Scopus subject areas
- Molecular Biology